Revenue remained stable year-on-year, but profitability was hit by sharp cost inflation from the Iran conflict, with EBITDA margin dropping to 16.1%. Price increases are expected to offset only half of the EUR 100 million cost impact in 2026, with full benefits seen in Q4.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.